PROFILE OF PATIENTS WITH MULTIDRUG-RESISTANT PULMONARY TUBERCULOSIS AT MERAUKE REGIONAL GENERAL HOSPITAL, MERAUKE REGENCY, SOUTH PAPUA, JANUARY 2021 – DECEMBER 2024

Achmad, Luana N. and Aritonang, Jimmi M. P. and Puspitasari, Febtusia and Pariama, Ganda (2026) PROFILE OF PATIENTS WITH MULTIDRUG-RESISTANT PULMONARY TUBERCULOSIS AT MERAUKE REGIONAL GENERAL HOSPITAL, MERAUKE REGENCY, SOUTH PAPUA, JANUARY 2021 – DECEMBER 2024. Journal of Innovation Research and Knowledge, 5 (8). pp. 5-8. ISSN 2798-3641

	Text PROFILEOFPATIENTSWITHMULTIDRUGRESISTANTPULMONARYTUBERCULOSISATMERAUKEREGIONALGENERALHOSPITALMERAUKEREGENCYSOUTHPAPUAJANUARY2021DECEMBER2024.pdf Download (396kB)
	Text (Hasil_Turnitin) HasilTurnitinPROFILEOFPATIENTSWITHMULTIDRUGRESISTANTPULMONARYTUBERCULOSISATMERAUKEREGIONALGENERALHOSPITALMERAUKEREGENCYSOUTHPAPUAJANUARY2021DECEMBER2024.pdf Download (523kB)

Abstract

Pulmonary MDR-TB is tuberculosis that is resistant to first-line drugs, especially isoniazid and rifampicin, due to genetic mutations at drug target sites, so it requires combinations of drugs from Groups A and B, and if needed, Group C. This descriptive study used medical records of MDR-TB patients treated at Merauke Regional Hospital from January 2021 to December 2024 and was analyzed univariately with SPSS version 26. Most patients were 18–59 years old (90.6%), female (53.1%), and had a history of previous TB treatment (89.3%), with a small proportion experiencing treatment interruption and treatment failure. Comorbidities included diabetes mellitus (6.3%) and HIV (18.8%), and the mortality rate was relatively high at 40.6%.

Actions (login required)

View Item